Dr Gonzales presented the history and development of Serene, LLC, and its many products and opportunities related to Sn-117m.
Dr Stevenson discussed manufacturing of the homogeneous Sn-117m colloid as well as other Sn-117m-related products.
Dr Doerr presented data related to the pre-clinical trials in rats and dogs related to homogeneous Sn-117m colloid, and human clinical trials that will begin in Canada in 2018.
Today Serene LLC's veterinary subsidiary, Convetra Inc, completed enrollment of a clinical trial involving reinjecting Synovetin-OA in client-owned dog with naturally occurring Grade 1-3 osteoarthritis of the elbow. These subjects will be followed for twelve months, with results reported in…